Moderna director receives RSU and option grants
Moderna, Inc. director David M. Rubenstein reported new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Moderna, Inc. director David M. Rubenstein reported new equity awards. On May 6, 2026, he received 2,092 restricted stock units, each convertible into one share of common stock.
He was also granted 9,681 stock options with an exercise price of $48.79 per share, expiring on May 6, 2036. Both the RSUs and options vest in full on the earlier of May 6, 2027 or Moderna's next Annual Meeting of Shareholders, subject to his continued service.
Insider Trade Summary
Grant/Award: 11,773 shares
Grant/Award
2 txns
Insider
Rubenstein David M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,681 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,092 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,681 contracts (Direct);
Restricted Stock Units — 2,092 contracts (Direct)
Footnotes (3)
- F1. This option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
- F2. Restricted stock units convert into common stock on a one-for-one basis.
- F3. The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
Key Figures
RSU grant size: 2,092 RSUs
Option grant size: 9,681 options
Option exercise price: $48.79 per share
+5 more
8 metrics
RSU grant size
2,092 RSUs
Granted on May 6, 2026 to director David M. Rubenstein
Option grant size
9,681 options
Granted on May 6, 2026 to purchase common stock
Option exercise price
$48.79 per share
Conversion or exercise price for 9,681 stock options
Option expiration
May 6, 2036
Expiration date of Rubenstein’s stock option award
RSU vesting date
May 6, 2027 or next Annual Meeting
Full vesting trigger for 2,092 RSUs, subject to continued service
Option vesting date
May 6, 2027 or next Annual Meeting
Full vesting and exercisability trigger for 9,681 options
RSUs after transaction
2,092 RSUs
Total restricted stock units held following the award
Options after transaction
9,681 options
Total stock options held following the award
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), vested and exercisable, Annual Meeting of Shareholders, +1 more
5 terms
Restricted Stock Units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 48.7900."
vested and exercisable financial
"This option will become fully vested and exercisable on the earlier of May 6, 2027..."
exercise price financial
"conversion or exercise price of 48.7900 for the stock option award."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Moderna (MRNA) director David M. Rubenstein report?
David M. Rubenstein reported receiving equity awards from Moderna, not open-market trades. He was granted 2,092 restricted stock units and 9,681 stock options, both tied to his continued service and vesting by the earlier of May 6, 2027, or the next Annual Meeting.
How many RSUs did Moderna (MRNA) grant to director David M. Rubenstein?
Moderna granted David M. Rubenstein 2,092 restricted stock units. Each RSU converts into one share of common stock and will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, assuming he continues to serve.
What are the terms of David M. Rubenstein’s stock options from Moderna (MRNA)?
Rubenstein received 9,681 stock options with a $48.79 exercise price. These options become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, provided he continues his service, and they expire on May 6, 2036.
Do the Moderna (MRNA) Form 4 transactions involve stock being bought or sold on the market?
The Form 4 shows equity awards, not market purchases or sales. Rubenstein acquired RSUs and stock options as compensation, both granted at a reported price of $0.00 per unit, with vesting and exercisability dependent on his continued service as a director.
When will David M. Rubenstein’s Moderna (MRNA) RSUs and options vest?
Both the RSUs and options are scheduled to vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting. Vesting is subject to Rubenstein's continued service, aligning the awards' benefits with his ongoing role on the company’s board.
AI-generated analysis. How Rhea-AI works. Not financial advice.
